Immunic: Fourth Quarter Financial Overview

Immunic, Inc. Announces Fourth Quarter Financial Results

Immunic, Inc. (IMUX), headquartered in New York, disclosed a fourth-quarter net loss totaling $19.3 million.

The company reported a loss of $0.12 per share for the quarter.

These figures did not meet analysts' expectations, as a consensus of six experts polled by Zacks Investment Research had anticipated a loss of $0.10 per share.

For the full fiscal year, Immunic, Inc. recorded a net loss of $97.2 million, which equates to $0.62 per share.